Puma Biotechnology, Inc.PBYINASDAQ
Loading
EBITDA as a percentage of revenue
3Y CAGR
+39.1%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
2.7x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 25.84% | +23.9% |
| 2024 | 20.86% | +3.4% |
| 2023 | 20.17% | +110.1% |
| 2022 | 9.60% | +618.1% |
| 2021 | -1.85% | +88.3% |
| 2020 | -15.86% | +17.7% |
| 2019 | -19.26% | +49.2% |
| 2018 | -37.93% | +96.4% |
| 2017 | -1041.24% | - |
| 2016 | 0.00% | - |